Delivery Order SPE2DB22D2206-SPE2DB26FDS78
- Not listed
- The Defense Logistics Agency awarded a $28,423.85 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tobi Podhaler 28 mg inhalable capsules (56-count unit dose). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is set for completion by September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same city. The...
- The Defense Logistics Agency awarded a $26,268.09 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tobi Podhaler 28 mg inhale capsules (56-unit doses). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $33,712.95 delivery order to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on June 2, 2025, with completion scheduled for June 3, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $93,709.93 to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $41,719.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on August 19, 2025, with completion targeted for August 20, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric and adult cystic fibrosis treatment, positioning the pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,972.30, is for the supply of the pharmaceutical product Tobi Podhaler 28 mg inhalation capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,075.64 firm fixed-price delivery order is for the supply of 4,566,359,280 units of the medication Tobi Podhaler 28 mg inhalation capsules. The contract has an ultimate completion date of November 7, 2024 and was awarded on November 6, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBI PODHALER 28 MG INHALE CAP UD 56S, with an ultimate completion date of July 18, 2025 and a ceiling value of $61,724.87. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The federal contract award SPE2DB22D3004|SPE2DB24FPS54 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $15,245.43 firm fixed price delivery order is for the supply of 4,564,030,051 units of the pharmaceutical product Tobi Podhaler 28 mg Inhalation Capsules. This award is part of a larger $999,999,999.00 indefinite delivery contract held by Amerisourcebergen Drug Corp to provide a...
- The Defense Logistics Agency awarded a $24,342 delivery order to Amerisourcebergen Drug Corporation for 56 units of 28 mg Tobramycin inhalation capsules to be delivered to a location in Conshohocken, Pennsylvania. The firm fixed price order is being funded by the Defense Logistics Agency and will provide Tobramycin inhalation capsules, used to treat cystic fibrosis, to support the agency's medical supply needs. Amerisourcebergen Drug Corporation will perform the order from its corporate...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS78Delivery Order
The Defense Logistics Agency awarded a $12,555.40 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Tobi Podhaler 28 mg inhalation capsules (56-count unit dose). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through competitive award of its contracts with the Defense Logistics Agency and related military healthcare systems. The company's federal portfolio encompasses an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Tobi Podhaler, a tobramycin inhalation powder used in respiratory treatments, represents a routine fulfillment of the company's role as a primary pharmaceutical distributor supporting military and Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 10/22/25 |